UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Alberta Investment Management Corp

Alberta Investment Management Corp grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 211.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 24,915 shares of the healthcare conglomerate's stock after acquiring an additional 16,915 shares during the period. Alberta Investment Management Corp's holdings in UnitedHealth Group were worth $12,604,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of UNH. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth $30,000. RPg Family Wealth Advisory LLC purchased a new stake in UnitedHealth Group in the third quarter valued at $37,000. DecisionPoint Financial LLC lifted its position in UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock valued at $52,000 after acquiring an additional 62 shares during the last quarter. Highline Wealth Partners LLC purchased a new stake in UnitedHealth Group in the third quarter valued at $55,000. Finally, Legacy Investment Solutions LLC purchased a new stake in UnitedHealth Group in the third quarter valued at $57,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded down $36.84 on Friday, hitting $465.58. The company had a trading volume of 19,847,353 shares, compared to its average volume of 4,805,500. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The business has a 50 day moving average of $519.27 and a 200 day moving average of $560.54. The company has a market cap of $428.46 billion, a PE ratio of 30.04, a PEG ratio of 1.40 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business's quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $5.83 earnings per share. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the company's stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.33% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on UNH shares. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Piper Sandler dropped their target price on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. Truist Financial dropped their target price on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Cantor Fitzgerald reissued an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a research note on Tuesday, December 3rd. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.